This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 14 - 17, 2025
Marriott Marquis San DiegoLive In-Person Event: December 14 - 17, 2025

Nicholas Marshall, PhD
Head of Protein Sciences at Invenra
Speaker

Profile

Nicholas Marshall, PhD, adds a diverse background in protein biochemistry, biophysical characterization, protein engineering, and process development to Invenra. As the leader of the Protein Sciences group, Nick oversees production and characterization of R&D phase molecules, including biophysical characterization and developability assessments of lead molecules. Nick brings more than 10 years of experience in therapeutic protein discovery and drug development. Prior to joining Invenra, Nick worked in Process Chemistry Research and Development at Merck (MSD), where he used directed evolution and high throughput methods to develop enzymes needed for biocatalytic synthesis of active pharmaceutical ingredients. Before Merck, Nick worked with Everett Stone and George Georgiou at the University of Texas at Austin to discover therapeutic enzymes for immune oncology. Nick holds a PhD in Chemical Biology from the University of Illinois where he studied electron transfer in proteins.

Agenda Sessions

  • T-Body: A Novel Trispecific Antibody Platform to Accelerate and De-Risk Drug Discovery

    12:35pm